These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 35859328

  • 21. Safety and efficacy of pegylated recombinant human granulocyte colony-stimulating factor during concurrent chemoradiotherapy for small-cell lung cancer: a retrospective, cohort-controlled trial.
    Wang C, Zhu S, Miao C, Wang Y, Chen J, Yuan S, Hu X.
    BMC Cancer; 2022 May 13; 22(1):542. PubMed ID: 35562713
    [Abstract] [Full Text] [Related]

  • 22. Clinical efficacy and safety of mecapegfilgrastim in small cell lung cancer as primary prophylaxis of neutropenia post chemotherapy: a retrospective analysis.
    Gu X, Zhang Y.
    Ann Palliat Med; 2021 Jul 13; 10(7):7841-7846. PubMed ID: 34353071
    [Abstract] [Full Text] [Related]

  • 23. Low-dose pegylated recombinant human granulocyte-colony stimulating factor as hematopoietic support for adjuvant chemotherapy in Chinese patients with breast cancer: An open-label, randomized, non-inferiority trial.
    Yang S, Chen SS, Zhang CG, Zhou YL, Xiu M, Zhang P.
    Br J Clin Pharmacol; 2024 Oct 13; 90(10):2621-2629. PubMed ID: 38925586
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Clinical study of recombinant human granulocyte colony-stimulating factor (RHG-CSF) on leucopenia induced by chemotherapy with CE regimen on lung cancer patients].
    Shi YK, Feng FY, Sun Y.
    Zhonghua Nei Ke Za Zhi; 1994 Nov 13; 33(11):739-42. PubMed ID: 7541325
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Docetaxel Plus RAmucirumab With Primary Prophylactic Pegylated Granulocyte-ColONy Stimulating Factor Support for Elderly Patients With Advanced Non-small-cell Lung Cancer: A Multicenter Prospective Single Arm Phase II Trial: DRAGON Study (WJOG9416L).
    Hata A, Katakami N, Shimokawa M, Mitsudomi T, Yamamoto N, Nakagawa K.
    Clin Lung Cancer; 2018 Nov 13; 19(6):e865-e869. PubMed ID: 30206044
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Efficacy, safety, and cost-effectiveness of pegylated PEG-rhg-CSF in pediatric patients receiving high-intensity chemotherapy: results from a phase II study.
    Huang J, Zhu J, Jiang L, Xu J, Lin X, Chang J, Zhang X, Lu S, Sun F, Wang J, Que Y, Ye Z, Yang L, Yuan X, Cai W, Tian C, Wu Y, He X, Tang YL, Zhang Y.
    Front Pharmacol; 2024 Nov 13; 15():1419369. PubMed ID: 39086394
    [Abstract] [Full Text] [Related]

  • 32. Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.
    Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G.
    N Engl J Med; 1991 Jul 18; 325(3):164-70. PubMed ID: 1711156
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
    Timmer-Bonte JN, de Boo TM, Smit HJ, Biesma B, Wilschut FA, Cheragwandi SA, Termeer A, Hensing CA, Akkermans J, Adang EM, Bootsma GP, Tjan-Heijnen VC.
    J Clin Oncol; 2005 Nov 01; 23(31):7974-84. PubMed ID: 16258098
    [Abstract] [Full Text] [Related]

  • 35. [A single-center, randomized controlled trial of PEG-rhG-CSF and common rhG-CSF to promote neutrophil recovery after induction chemotherapy in newly diagnosed acute myeloid leukemia].
    Liu KQ, Wang Y, Zhao Z, Lin D, Zhou CL, Liu BC, Gong XY, Zhao XL, Wei SN, Zhang GJ, Gong BF, Li Y, Liu YT, Mi YC, Wang JX, Wei H.
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jun 14; 40(6):497-501. PubMed ID: 31340623
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics and safety of pegylated recombinant human granulocyte colony-stimulating factor in children with acute leukaemia.
    Liu XT, Zhao YX, Jia GW, Yang F, Zhang CZ, Han B, Dai JH, Han YQ, Tang BH, Yang XM, Shi HY, Zhou Y, Sui ZG, Chen JZ, van den Anker JN, Zhao W.
    Br J Clin Pharmacol; 2021 Aug 14; 87(8):3292-3300. PubMed ID: 33506975
    [Abstract] [Full Text] [Related]

  • 37. Clinical observation of the therapeutic effects of pegylated recombinant human granulocyte colony-stimulating factor in patients with concurrent chemoradiotherapy-induced grade IV neutropenia.
    Wu FP, Wang J, Wang H, Li N, Guo Y, Cheng YJ, Liu Q, Yang XR.
    Exp Ther Med; 2015 Mar 14; 9(3):761-765. PubMed ID: 25667625
    [Abstract] [Full Text] [Related]

  • 38. Prophylactic administration of mecapegfilgrastim after chemotherapy in patients with lymphoma.
    Zheng M, Wen X, Su L.
    Ann Palliat Med; 2021 Dec 14; 10(12):12055-12060. PubMed ID: 35016412
    [Abstract] [Full Text] [Related]

  • 39. Mecapegfilgrastim in Chemotherapy-Induced Neutropenia: A Profile of Its Use in China.
    Al-Salama ZT, Keam SJ.
    Clin Drug Investig; 2019 Oct 14; 39(10):1009-1018. PubMed ID: 31489570
    [Abstract] [Full Text] [Related]

  • 40. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.
    Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C, European Organisation for Research and Treatment of Cancer.
    Eur J Cancer; 2011 Jan 14; 47(1):8-32. PubMed ID: 21095116
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.